HK1171018A1 - -二氫- -硝基咪唑並 噁唑化合物 - Google Patents
-二氫- -硝基咪唑並 噁唑化合物Info
- Publication number
- HK1171018A1 HK1171018A1 HK12111863.7A HK12111863A HK1171018A1 HK 1171018 A1 HK1171018 A1 HK 1171018A1 HK 12111863 A HK12111863 A HK 12111863A HK 1171018 A1 HK1171018 A1 HK 1171018A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nitroimidazo
- oxazoles
- dihydro
- Prior art date
Links
- QISRGAUYEHQMJV-UHFFFAOYSA-N 6-nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazole Chemical class C1COC2=NC([N+](=O)[O-])=CN21 QISRGAUYEHQMJV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002298259 | 2002-10-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1171018A1 true HK1171018A1 (zh) | 2013-03-15 |
Family
ID=32089299
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06101486A HK1085463A1 (en) | 2002-10-11 | 2006-02-03 | 2,3-dihydro-6-nitroimidazo (2,1-b) oxazoles |
HK12111863.7A HK1171018A1 (zh) | 2002-10-11 | 2012-11-21 | -二氫- -硝基咪唑並 噁唑化合物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06101486A HK1085463A1 (en) | 2002-10-11 | 2006-02-03 | 2,3-dihydro-6-nitroimidazo (2,1-b) oxazoles |
Country Status (27)
Country | Link |
---|---|
US (1) | US7262212B2 (zh) |
EP (2) | EP1555267B1 (zh) |
JP (1) | JP4186065B2 (zh) |
KR (1) | KR100723847B1 (zh) |
CN (4) | CN101172981A (zh) |
AR (4) | AR041198A1 (zh) |
AU (1) | AU2003272979B2 (zh) |
BE (1) | BE2014C053I2 (zh) |
BR (1) | BRPI0314344B8 (zh) |
CA (1) | CA2497569C (zh) |
CY (2) | CY1113578T1 (zh) |
DK (1) | DK1555267T3 (zh) |
ES (1) | ES2400179T3 (zh) |
FR (1) | FR14C0066I2 (zh) |
HK (2) | HK1085463A1 (zh) |
HU (1) | HUS1400046I1 (zh) |
LU (1) | LU92517I2 (zh) |
MX (1) | MXPA05003674A (zh) |
MY (1) | MY139244A (zh) |
PL (3) | PL409525A1 (zh) |
PT (1) | PT1555267E (zh) |
RU (1) | RU2326121C3 (zh) |
SI (1) | SI1555267T1 (zh) |
TW (1) | TWI347946B (zh) |
UA (1) | UA83200C2 (zh) |
WO (1) | WO2004033463A1 (zh) |
ZA (1) | ZA200501033B (zh) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60144284D1 (de) | 2000-11-01 | 2011-05-05 | Millennium Pharm Inc | Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung |
US7368579B2 (en) | 2002-10-15 | 2008-05-06 | Otsuka Pharmaceutical Co., Ltd. | 1-substituted-4-nitroimidazole compound and process for producing the same |
JP4761756B2 (ja) * | 2003-10-31 | 2011-08-31 | 大塚製薬株式会社 | 2,3−ジヒドロイミダゾ[2,1−b]オキサゾ−ル化合物 |
ATE410430T1 (de) * | 2003-10-31 | 2008-10-15 | Otsuka Pharma Co Ltd | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose |
TWI300409B (en) | 2004-02-18 | 2008-09-01 | Otsuka Pharma Co Ltd | Method for producing 4-nitroimidazole compound |
EP2650290A1 (en) | 2004-03-31 | 2013-10-16 | Nippon Soda Co., Ltd. | Cyclic amine compound and pest control agent |
JP4787529B2 (ja) * | 2004-04-09 | 2011-10-05 | 大塚製薬株式会社 | 医薬組成物 |
JP4789966B2 (ja) * | 2004-04-09 | 2011-10-12 | 大塚製薬株式会社 | 医薬組成物 |
ES2337728T3 (es) * | 2005-06-20 | 2010-04-28 | Schering Corporation | Piperidinas sustituidas unidas a carbono y sus derivados utiles como antagonistas de histamina h3. |
MX2008001210A (es) * | 2005-07-28 | 2008-03-24 | Otsuka Pharma Co Ltd | Composicion farmaceutica que comprende derivados de 2,3-dihidro-6-nitroimidazo{2,1-b]oxazol. |
JP5105818B2 (ja) * | 2005-10-05 | 2012-12-26 | 大塚製薬株式会社 | 医薬組成物 |
TWI368509B (en) * | 2005-10-05 | 2012-07-21 | Otsuka Pharma Co Ltd | Antituberculous therapeutic drugs and kit containing the same |
BRPI0616839A2 (pt) | 2005-10-06 | 2013-01-01 | Nippon Soda Co | agentes para controle de praga, e, compostos de amina cìclicos |
TW200800268A (en) | 2005-11-04 | 2008-01-01 | Otsuka Pharma Co Ltd | Medicinal composition showing improved drug absorbability |
EP1968961A2 (en) | 2005-12-21 | 2008-09-17 | Decode Genetics EHF | Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
EP1986637A1 (en) * | 2006-02-13 | 2008-11-05 | Laboratoires Serono SA | Sulfonamide derivatives for the treatment of bacterial infections |
JP2007297305A (ja) * | 2006-04-28 | 2007-11-15 | Daiso Co Ltd | N−(2,3−エポキシ−2−メチルプロピル)フタルイミドの製造法 |
EP2125750B1 (en) * | 2007-02-26 | 2014-05-21 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
AR070301A1 (es) | 2007-05-08 | 2010-03-31 | Otsuka Pharma Co Ltd | Compuesto epoxi y metodo para producir el mismo |
ES2395081T3 (es) * | 2007-07-26 | 2013-02-08 | Vitae Pharmaceuticals, Inc. | Síntesis de inhibidores de la 11beta-hidroxiesteroide deshidrogenasa de tipo 1 |
TW200922581A (en) * | 2007-08-15 | 2009-06-01 | Glaxo Group Ltd | Compounds |
WO2009050204A1 (en) * | 2007-10-16 | 2009-04-23 | Glaxo Group Limited | Quinoline derivatives used to treat inflammatory and allergic diseases |
AR069207A1 (es) * | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
US8440658B2 (en) | 2007-12-11 | 2013-05-14 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
TW200934490A (en) * | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
EP2252601B1 (en) | 2008-01-24 | 2012-12-19 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
CA2714532A1 (en) * | 2008-02-11 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
WO2009102460A2 (en) * | 2008-02-15 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
CA2718264A1 (en) * | 2008-03-18 | 2009-09-24 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
US7666864B2 (en) * | 2008-03-26 | 2010-02-23 | Global Alliance For Tb Drug Development | Bicyclic nitroimidazole-substituted phenyl oxazolidinones |
US8569292B2 (en) | 2008-05-01 | 2013-10-29 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
JP5538365B2 (ja) | 2008-05-01 | 2014-07-02 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤 |
US8242111B2 (en) * | 2008-05-01 | 2012-08-14 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
ES2421537T3 (es) | 2008-05-01 | 2013-09-03 | Vitae Pharmaceuticals Inc | Inhibidores cíclicos de la 11beta-hidroxiesteroide deshidrogenasa 1 |
PL2324018T3 (pl) | 2008-07-25 | 2014-02-28 | Boehringer Ingelheim Int | Cykliczne inhibitory dehydrogenazy 11 beta-hydroksysteroidowej typu 1 |
JP5777030B2 (ja) | 2008-07-25 | 2015-09-09 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤 |
CN102186833A (zh) * | 2008-08-18 | 2011-09-14 | 耶鲁大学 | Mif调节剂 |
US9643922B2 (en) | 2008-08-18 | 2017-05-09 | Yale University | MIF modulators |
US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
WO2010021409A1 (en) | 2008-08-21 | 2010-02-25 | Dynamit Nobel Gmbh Explosivstoff - Und Systemtechnik | Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof |
WO2010143007A1 (en) * | 2009-06-10 | 2010-12-16 | Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik | Method for the production of 2-halogeno-4-nitroimidazole |
EP2393807B1 (en) | 2009-02-04 | 2013-08-14 | Boehringer Ingelheim International GmbH | Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1 |
TW201039034A (en) * | 2009-04-27 | 2010-11-01 | Chunghwa Picture Tubes Ltd | Pixel structure and the method of forming the same |
GEP20156309B (en) * | 2009-04-30 | 2015-07-10 | Vitae Pharmaceuticals Inc | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
UA109255C2 (ru) | 2009-04-30 | 2015-08-10 | Берінгер Інгельхайм Інтернешнл Гмбх | Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1 |
JP5656986B2 (ja) | 2009-06-11 | 2015-01-21 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 1,3−オキサジナン−2−オン構造に基づく11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤 |
EP2448928B1 (en) | 2009-07-01 | 2014-08-13 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
WO2011014774A1 (en) * | 2009-07-31 | 2011-02-03 | Global Alliance For Tb Drug Development | Nitroimidazooxazines and their uses in anti-tubercular therapy |
NZ598165A (en) * | 2009-07-31 | 2013-05-31 | Global Alliance For Tb Drug Dev | Nitroimidazooxazine and nitroimidazooxazole analogues and their uses |
US9198913B2 (en) | 2009-07-31 | 2015-12-01 | Global Alliance For Tb Drug Development | Nitroimidazooxazines and their uses in anti-tubercular therapy |
WO2011052522A1 (ja) | 2009-10-26 | 2011-05-05 | 富士フイルムRiファーマ株式会社 | 感染症診断薬 |
TW201200523A (en) | 2010-01-29 | 2012-01-01 | Otsuka Pharma Co Ltd | Synthetic intermediate of oxazole compound and method for producing the same |
GB201012209D0 (en) * | 2010-05-31 | 2010-09-08 | Ge Healthcare Ltd | In vivo imaging agent |
EP2582698B1 (en) | 2010-06-16 | 2016-09-14 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
JP5813106B2 (ja) | 2010-06-25 | 2015-11-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン |
CA2813671A1 (en) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
EP2697232B1 (en) | 2011-04-15 | 2016-05-18 | Otsuka Pharmaceutical Co., Ltd. | 6,7-dihydroimidazo[2,1-b][1,3]oxazine bactericides |
JP2015006994A (ja) * | 2011-10-28 | 2015-01-15 | 大正製薬株式会社 | ジヒドロイミダゾオキサゾール誘導体 |
WO2014014845A1 (en) | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases |
FR3000064A1 (fr) | 2012-12-21 | 2014-06-27 | Univ Lille Ii Droit & Sante | Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes |
EP3052503B1 (en) | 2013-10-04 | 2018-10-24 | Council of Scientific & Industrial Research | 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof |
CN103524492A (zh) * | 2013-10-23 | 2014-01-22 | 中国药科大学 | 侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途 |
TWI687409B (zh) | 2014-08-28 | 2020-03-11 | 日商大塚製藥股份有限公司 | 稠合雜環化合物 |
JP6467042B2 (ja) * | 2014-10-21 | 2019-02-06 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | 抗マイコバクテリア剤としての置換1,2,3−トリアゾール−1−イル−メチル−2,3−ジヒドロ−2−メチル−6−ニトロイミダゾ[2,1−b]オキサゾールとその調製方法 |
CN105732659B (zh) * | 2014-12-12 | 2019-07-16 | 上海阳帆医药科技有限公司 | 硝基咪唑类化合物及其制备方法和在制药中的用途 |
TW201632533A (zh) * | 2015-01-29 | 2016-09-16 | 南京明德新藥研發股份有限公司 | 抗肺結核病的硝基咪唑衍生物 |
CN107406386B (zh) * | 2015-03-27 | 2021-06-01 | 大塚制药株式会社 | 用于生产1-(4-羟基苯基)-4-(4-三氟甲氧基苯氧基)哌啶或其盐的方法 |
CN106317072B (zh) * | 2015-06-17 | 2020-03-17 | 盟科医药技术(上海)有限公司 | 用于分枝杆菌感染治疗的杂环化合物及其应用 |
WO2017146246A1 (ja) | 2016-02-26 | 2017-08-31 | 大塚製薬株式会社 | ピペリジン誘導体 |
CN105859628B (zh) * | 2016-04-19 | 2018-08-07 | 清远职业技术学院 | 一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用 |
RU2019104974A (ru) * | 2016-07-22 | 2020-08-24 | Медшайн Дискавери Инк. | Кристалл и соль нитроимидазола и способ их изготовления |
MX2020001808A (es) | 2017-08-16 | 2022-07-19 | Glaxosmithkline Ip Dev Ltd | Nuevos compuestos. |
CN112236141A (zh) | 2018-06-11 | 2021-01-15 | 大塚制药株式会社 | 包含德拉马尼的组合物 |
CN109705022A (zh) * | 2018-12-28 | 2019-05-03 | 上海彩迩文生化科技有限公司 | 一种芳香胺中间体的制备方法 |
CN112300192B (zh) * | 2019-08-02 | 2023-08-11 | 南京长澳医药科技有限公司 | 硝基咪唑类化合物及其制备方法和用途 |
CN110483549B (zh) * | 2019-08-30 | 2021-03-05 | 沈阳药科大学 | 一种硝基咪唑吡喃类抗结核药物的制备方法 |
CN110615800A (zh) * | 2019-10-16 | 2019-12-27 | 李丽丽 | 硝基咪唑类化合物及其制备方法和用途 |
CN112156088B (zh) * | 2020-10-30 | 2021-08-31 | 健民药业集团股份有限公司 | 一种化合物在制备结核分枝杆菌抑制剂中的用途 |
CN113603706A (zh) * | 2021-08-04 | 2021-11-05 | 深圳市泰力生物医药有限公司 | 德拉马尼的晶型、含有该晶型的活性药物和药物组合物 |
CN115368252B (zh) * | 2022-09-19 | 2024-01-12 | 西北农林科技大学 | 一种4-胺基酚类衍生物及应用 |
CN116640106B (zh) * | 2023-05-11 | 2024-03-08 | 郑州大学 | 一种苯基哌嗪类化合物及其制备方法、应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5668127A (en) | 1995-06-26 | 1997-09-16 | Pathogenesis Corporation | Nitroimidazole antibacterial compounds and methods of use thereof |
-
2003
- 2003-10-09 TW TW092128165A patent/TWI347946B/zh not_active IP Right Cessation
- 2003-10-09 AR ARP030103673A patent/AR041198A1/es active IP Right Grant
- 2003-10-10 EP EP03754085A patent/EP1555267B1/en not_active Expired - Lifetime
- 2003-10-10 KR KR1020057004567A patent/KR100723847B1/ko active Protection Beyond IP Right Term
- 2003-10-10 ES ES03754085T patent/ES2400179T3/es not_active Expired - Lifetime
- 2003-10-10 EP EP12193820.3A patent/EP2570418A3/en not_active Withdrawn
- 2003-10-10 UA UAA200504391A patent/UA83200C2/ru unknown
- 2003-10-10 CA CA2497569A patent/CA2497569C/en not_active Expired - Lifetime
- 2003-10-10 MX MXPA05003674A patent/MXPA05003674A/es active IP Right Grant
- 2003-10-10 PL PL409525A patent/PL409525A1/pl unknown
- 2003-10-10 PT PT37540853T patent/PT1555267E/pt unknown
- 2003-10-10 CN CNA2007100040367A patent/CN101172981A/zh active Pending
- 2003-10-10 CN CNB2003801017508A patent/CN100366624C/zh not_active Expired - Lifetime
- 2003-10-10 PL PL376157A patent/PL217919B1/pl unknown
- 2003-10-10 MY MYPI20033866A patent/MY139244A/en unknown
- 2003-10-10 US US10/530,429 patent/US7262212B2/en not_active Expired - Lifetime
- 2003-10-10 WO PCT/JP2003/013070 patent/WO2004033463A1/ja active Application Filing
- 2003-10-10 CN CNA2007100040371A patent/CN101255170A/zh active Pending
- 2003-10-10 BR BRPI0314344A patent/BRPI0314344B8/pt active IP Right Grant
- 2003-10-10 CN CN201110416170.4A patent/CN102532162B/zh not_active Expired - Lifetime
- 2003-10-10 AU AU2003272979A patent/AU2003272979B2/en not_active Expired
- 2003-10-10 RU RU2005114017A patent/RU2326121C3/ru active Protection Beyond IP Right Term
- 2003-10-10 DK DK03754085.3T patent/DK1555267T3/da active
- 2003-10-10 SI SI200332254T patent/SI1555267T1/sl unknown
- 2003-10-10 PL PL404913A patent/PL404913A1/pl unknown
- 2003-10-14 JP JP2003353868A patent/JP4186065B2/ja not_active Expired - Lifetime
-
2005
- 2005-02-03 ZA ZA200501033A patent/ZA200501033B/en unknown
-
2006
- 2006-02-03 HK HK06101486A patent/HK1085463A1/xx not_active IP Right Cessation
-
2012
- 2012-04-23 AR ARP120101394A patent/AR086485A2/es unknown
- 2012-11-21 HK HK12111863.7A patent/HK1171018A1/zh not_active IP Right Cessation
-
2013
- 2013-01-25 CY CY20131100076T patent/CY1113578T1/el unknown
- 2013-02-08 AR ARP130100408A patent/AR089950A2/es unknown
- 2013-07-15 AR ARP130102514 patent/AR091771A2/es not_active Application Discontinuation
-
2014
- 2014-08-13 LU LU92517C patent/LU92517I2/xx unknown
- 2014-08-14 HU HUS1400046C patent/HUS1400046I1/hu unknown
- 2014-09-09 BE BE2014C053C patent/BE2014C053I2/fr unknown
- 2014-09-11 FR FR14C0066C patent/FR14C0066I2/fr active Active
- 2014-09-24 CY CY2014041C patent/CY2014041I1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1171018A1 (zh) | -二氫- -硝基咪唑並 噁唑化合物 | |
DE60302150D1 (en) | N-substituiete heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trion metalloproteinase inhibitoren | |
HK1086556A1 (en) | Fused 1,3-dihydro-imidazole ring compounds | |
AP2223A (en) | Pramipexole once-daily dosage form. | |
AU2003229878A1 (en) | Machine translation | |
IL163749A0 (en) | Novel florfenicol-type antibiotics | |
EP1575881A3 (en) | Alanine 2,3- aminomutase | |
HK1078568A1 (en) | 2-(2,6-dichlorophenyl)-diarylimidazoles | |
AU2003288586A1 (en) | Electrode arrangement | |
AU2003255831A1 (en) | Delayed-gelation solution | |
AU2003241332A1 (en) | Keymat | |
AU2003294726A1 (en) | Window-winding arrangement | |
AU2003299648A1 (en) | Substituted 4-phenyl-(1,3)-dioxanes | |
AU2003289290A1 (en) | Remedy | |
HK1060379A1 (en) | Joiner. | |
AU2003221050A1 (en) | Remedy for hypermyotonia | |
ZA200403323B (en) | Anthelmintic composition. | |
AU2003243065A1 (en) | Grin-lens arrangement | |
AU2002331281A1 (en) | New uses for 2-amino-2-propane-1,3-diols | |
AU2003227940A1 (en) | Viscometers | |
AU2002323813A1 (en) | Turning machine | |
AU2003294885A1 (en) | Grouted sleeves | |
AU2003212346A1 (en) | Bio-sensors | |
AU2003906848A0 (en) | The multi-bit | |
AU2002950249A0 (en) | Improved sock |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20231005 |